Stay updated on Napabucasin Combo in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.

Latest updates to the Napabucasin Combo in Pancreatic Cancer Clinical Trial page
- Check3 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, with no change to the study information.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA 403 Forbidden error page is now shown for the study page, replacing the previous detailed study information with a standard error screen and a Home link. This indicates the page is currently inaccessible due to access restrictions.SummaryDifference17%

- Check45 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a minor update to the page’s underlying version. This change does not appear to modify the study details or user-facing content.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5. This appears to be a minor maintenance update to the page.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page displays a new revision label indicating v3.6.4, replacing the previous v3.6.3. This change represents a software version update and does not modify the study data or visible content.SummaryDifference0.0%

- Check102 days agoChange DetectedThe study documents now show Revision: v3.6.3, updating from v3.6.2. This indicates an updated protocol/document for the trial.SummaryDifference0.0%

Stay in the know with updates to Napabucasin Combo in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.